Common TitleALLY-3+
Official Title Daclatasvir, Sofosbuvir, and Ribavirin for Hepatitis C Virus Genotype 3 and Advanced Liver Disease: A Randomized Phase III study (ALLY-3+)
Phase Phase III
ClinicalTrials.gov NCT02319031
Treatments
Daclatasvir
Daclatasvir
Tradename:DaklinzaOther Names:DCVClass:DiscontinuedFunding
IndustryBristol-Myers Squibb